Exhibit 99.1
ALERE INC. ANNOUNCES
FOURTH QUARTER 2014 RESULTS
WALTHAM, MA…February 10, 2015…Alere Inc. (NYSE:ALR), a global leader in rapid diagnostics, announced its financial results for the quarter ended December 31, 2014.
Namal Nawana, Chief Executive Officer and President of Alere said, “We made substantial progress in the fourth quarter in refocussing Alere as the global leader in rapid diagnostics and delivering against our financial plans. Successfully closing the Alere Health divestiture in early January enabled us to substantially reduce our debt, and we continue to pursue the divestiture of other non-core assets. Importantly, we achieved 1.9% adjusted organic growth during the fourth quarter of 2014 driven by strong international sales growth. We also executed on our planned cost base change successfully in the fourth quarter of 2014, positioning us well for margin expansion in 2015.”
Financial results for the fourth quarter of 2014:
| | • | | As a result of our divestiture of Alere Health in early January 2015, the financial results presented for all periods reflect the reclassification of the Alere Health business as a discontinued operation. |
| | • | | Net revenue of $666.9 million for the fourth quarter of 2014, compared to $673.2 million for the fourth quarter of 2013. Non-GAAP adjusted net revenue was $667.1 million for the fourth quarter of 2014, compared to $673.6 million for the fourth quarter of 2013. |
| | • | | Net loss from continuing operations of $27.0 million attributable to common shareholders of Alere Inc., and respective net loss per diluted common share of $0.32 for the fourth quarter of 2014, compared to net loss from continuing operations of $4.4 million attributable to common shareholders of Alere Inc., and respective net loss per diluted common share of $0.06 for the fourth quarter of 2013. |
| | • | | Non-GAAP adjusted net income from continuing operations attributable to common shareholders of Alere Inc. per diluted common share of $0.60 for the fourth quarter of 2014, compared to non-GAAP adjusted net income from continuing operations attributable to common shareholders per diluted common share of $0.63 for the fourth quarter of 2013. |
| | • | | Net product and services revenue from our Professional Diagnostics segment was $598.7 million in the fourth quarter of 2014, compared to net product and services revenue of $600.7 million in the fourth quarter of 2013. Non-GAAP adjusted net product and services revenue from our Professional Diagnostics segment was $599.0 million in the fourth quarter of 2014, compared to non-GAAP adjusted net product and services revenue of $601.1 million in the fourth quarter of 2013. |
| | • | | U.S. influenza and meter-based Triage product revenues were $25.5 million and $17.8 million, respectively, for the fourth quarter of 2014, compared to $20.9 million and $17.7 million, respectively, for the fourth quarter of 2013. |
| | • | | Excluding the impact of the change in U.S. influenza revenues and the impact on revenues from the U.S. meter-based Triage product sales, currency-adjusted organic growth in our Professional Diagnostics segment was 1.9%. This increase reflects a 4.5% decrease in adjusted U.S. revenues, compared to the fourth quarter of 2013, offset by a 7.6% increase in our international business. The decrease in the U.S. business principally relates to lower revenues from INRatio sales and to lower pain management revenues in our Toxicology business. |
| | • | | Net product and services revenue from our Health Information Solutions segment was $34.7 million in the fourth quarter of 2014, compared to $30.8 million in the fourth quarter of 2013, reflecting growth in our Alere Home Monitoring patient self-testing services from $25.5 million in the fourth quarter of 2013 to $30.0 million in the fourth quarter of 2014. |
| | • | | Gross margin was 46.5% of net revenue in the fourth quarter of 2014, compared to 50.8% in the fourth quarter of 2013. Non-GAAP adjusted gross margins, which exclude from cost of net revenue amortization of acquisition-related intangibles, stock-based compensation expense, restructuring charges, and non-cash charges associated with acquired inventory, was 50.0% of non-GAAP adjusted net revenue in the fourth quarter of 2014, compared to 53.6% in the fourth quarter of 2013 and 49.8% in the third quarter of 2014. |
| | • | | Non-GAAP adjusted selling, general and administrative expenses were $176.4 million or 26.4% of adjusted net revenue in the fourth quarter of 2014, compared to $190.6 million or 28.3% of adjusted net revenue in the fourth quarter of 2013. Non-GAAP adjusted research and development expense was $25.6 million, or 3.8% of adjusted net revenue, compared to $35.7 million, or 5.3% of adjusted net revenue, in the fourth quarter of 2013. |
| | • | | Non-GAAP adjusted EBITDA from continuing operations for the fourth quarter of 2014 was $155.4 million, which reflects adjustments to add back non-interest related restructuring charges of $21.6 million, $0.2 million of acquisition-related costs and $5.8 million of costs associated with potential business dispositions. On a last-twelve-months basis, our non-GAAP adjusted EBITDA from continuing operations, with restructuring, acquisition and other costs added back, was $562.7 million. |
The Company’s GAAP results for continuing operations for the fourth quarter of 2014 exclude $0.3 million of revenue associated with acquired software license contracts that are not recognized due to business combination accounting rules and include $60.8 million of amortization, $21.6 million of restructuring charges, $4.7 million of stock-based compensation expense, $0.2 million of acquisition-related costs recorded in accordance with ASC 805,Business Combinations, $5.8 million of costs associated with potential business dispositions, $0.4 million of interest expense recorded in connection with fees paid for certain debt modifications, $0.2 million in compensation charges and $0.1 million of related interest accretion associated with acquisition-related contingent consideration obligations and $7.1 million in impairment and gain (loss) on dispositions, net, offset by the reversal of $4.8 million of expense recorded for fair value adjustments to acquisition-related contingent consideration.
The Company’s GAAP results for continuing operations for the fourth quarter of 2013 exclude $0.5 million of revenue associated with acquired software license contracts that are not recognized due to business combination accounting rules and include amortization of $70.5 million, $4.2 million of restructuring charges, $6.7 million of stock-based compensation expense, $1.3 million of acquisition-related costs recorded in accordance with ASC 805, Business Combinations, $6.1 million of costs associated with potential business dispositions, $0.4 million of interest expense recorded in connection with fees paid for certain debt modifications, $0.8 million in compensation charges and $0.1 million of related interest accretion associated with acquisition-related contingent consideration obligations, a $0.6 million charge associated with the write-up to fair market value of inventory acquired in connection with the acquisition of Epocal Inc., $0.1 million of costs associated with the proxy contest, offset by an $0.8 million reduction in the loss on disposition of our Spinreact, S.A. subsidiary located in Spain and $1.6 million of income recorded for fair value adjustments to acquisition-related contingent consideration.
Detailed reconciliations of the non-GAAP financial measures presented in this release to the most directly comparable financial measures under GAAP, as well as a discussion regarding these non-GAAP financial measures, are included in the schedules to this press release.
The Company will host a conference call beginning at 8:30 a.m. (Eastern Time) today, February 10, 2015, to discuss these results, as well as other corporate matters. During the conference call, the Company may answer questions concerning business and financial developments and trends and other business and financial matters. The Company’s responses to these questions, as well as other matters discussed during the conference call, may contain or constitute material information that has not been previously disclosed.
The conference call will be webcast live on the Investor Relations section of Alere’s website or accessed directly through the following link:http://www.videonewswire.com/event.asp?id=101458.
To access the conference call, please use the following dial-in numbers and access code 9692678:
US (toll-free): 1-888-317-6003
International: 1-412-317-6061
Canada (toll-free): 1-866-284-3684
A replay will be available approximately one hour after the conclusion of the call and will remain available for a period of seven days following the call. To hear a replay of the conference call, please use the following dial-in numbers and replay code 10059719 (available for seven days):
US (toll-free): 1-877-344-7529
International: 1-412-317-0088
Canada (toll-free): 1-855-669-9658
The replay will also be available via online webcast athttp://www.videonewswire.com/event.asp?id=101458 or via the Investor Relations section of the Alere website for a period of 60 days following the call.
Additionally, reconciliations to non-GAAP financial measures not included in this press release that may be discussed during the call will also be available at the Alere website (http://www.alere.com/us/en/about/investor-relations/events.html) under the Earnings Calls and Releases section shortly before the conference call begins and will continue to be available on this website.
For more information about Alere, please visit our web site athttp://www.alere.com.
About Alere
BecauseKnowing now matters™, Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.
###
Contact
Juliet Cunningham
Vice President, Investor Relations
858.805.2232
ir@alere.com
Alere Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
| | | | | | | | |
| | | Three Months Ended December 31, | |
| | | 2014 | | | 2013 | |
| | |
Net product sales and services revenue | | $ | 661,806 | | | $ | 659,039 | |
License and royalty revenue | | | 5,051 | | | | 14,116 | |
| | | | | | | | |
Net revenue | | | 666,857 | | | | 673,155 | |
Cost of net revenue | | | 356,526 | | | | 331,217 | |
| | | | | | | | |
Gross profit | | | 310,331 | | | | 341,938 | |
Gross margin | | | 47 | % | | | 51 | % |
| | |
Operating expenses: | | | | | | | | |
Research and development | | | 29,973 | | | | 38,324 | |
Selling, general and administrative | | | 237,793 | | | | 258,002 | |
Impairment and gain (loss) on dispositions, net | | | 7,104 | | | | (761 | ) |
| | | | | | | | |
Operating income | | | 35,461 | | | | 46,373 | |
Interest and other income (expense), net | | | (55,889 | ) | | | (56,293 | ) |
| | | | | | | | |
Loss from continuing operations before provision (benefit) for income taxes | | | (20,428 | ) | | | (9,920 | ) |
Provision (benefit) for income taxes | | | 4,836 | | | | (7,082 | ) |
| | | | | | | | |
Loss from continuing operations before equity earnings of unconsolidated entities, net of tax | | | (25,264 | ) | | | (2,838 | ) |
Equity earnings of unconsolidated entities, net of tax | | | 3,793 | | | | 4,205 | |
| | | | | | | | |
Loss from continuing operations | | | (21,471 | ) | | | 1,367 | |
Income (loss) from discontinued operations, net of tax | | | (1,444 | ) | | | (4,679 | ) |
| | | | | | | | |
Net loss | | | (22,915 | ) | | | (3,312 | ) |
Less: Net income (loss) attributable to non-controlling interests | | | 166 | | | | 375 | |
| | | | | | | | |
Net loss attributable to Alere Inc. and Subsidiaries | | | (23,081 | ) | | | (3,687 | ) |
| | |
Preferred stock dividends | | | (5,367 | ) | | | (5,367 | ) |
| | | | | | | | |
| | |
Net loss available to common stockholders | | $ | (28,448 | ) | | $ | (9,054 | ) |
| | | | | | | | |
| | |
Basic and diluted net loss per common share attributable to Alere Inc. and Subsidiaries: | | | | | | | | |
Loss from continuing operations | | $ | (0.32 | ) | | $ | (0.06 | ) |
Income (loss) from discontinued operations | | | (0.02 | ) | | | (0.05 | ) |
| | | | | | | | |
Net loss per common share | | $ | (0.34 | ) | | $ | (0.11 | ) |
| | | | | | | | |
| | |
Weighted average shares - basic and diluted | | | 83,586 | | | | 81,913 | |
| | | | | | | | |
Alere Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
| | | | | | | | |
| | | Year Ended December 31, | |
| | | 2014 | | | 2013 | |
| | |
Net product sales and services revenue | | $ | 2,565,640 | | | $ | 2,592,633 | |
License and royalty revenue | | | 21,050 | | | | 27,229 | |
| | | | | | | | |
Net revenue | | | 2,586,690 | | | | 2,619,862 | |
Cost of net revenue | | | 1,364,786 | | | | 1,297,485 | |
| | | | | | | | |
Gross profit | | | 1,221,904 | | | | 1,322,377 | |
Gross margin | | | 47 | % | | | 50 | % |
| | |
Operating expenses: | | | | | | | | |
Research and development | | | 144,828 | | | | 159,053 | |
Selling, general and administrative | | | 975,910 | | | | 997,796 | |
Impairment and gain (loss) on dispositions, net | | | 7,742 | | | | 5,124 | |
| | | | | | | | |
Operating income | | | 93,424 | | | | 160,404 | |
Interest and other income (expense), net | | | (211,924 | ) | | | (266,605 | ) |
| | | | | | | | |
Loss from continuing operations before provision (benefit) for income taxes | | | (118,500 | ) | | | (106,201 | ) |
Provision (benefit) for income taxes | | | 66,722 | | | | (35,359 | ) |
| | | | | | | | |
Loss from continuing operations before equity earnings of unconsolidated entities, net of tax | | | (185,222 | ) | | | (70,842 | ) |
Equity earnings of unconsolidated entities, net of tax | | | 17,509 | | | | 17,443 | |
| | | | | | | | |
Loss from continuing operations | | | (167,713 | ) | | | (53,399 | ) |
Income (loss) from discontinued operations, net of taxes | | | 2,637 | | | | (16,879 | ) |
| | | | | | | | |
Net loss | | | (165,076 | ) | | | (70,278 | ) |
Less: Net income (loss) attributable to non-controlling interests | | | 30 | | | | 976 | |
| | | | | | | | |
Net loss attributable to Alere Inc. and Subsidiaries | | | (165,106 | ) | | | (71,254 | ) |
| | |
Preferred stock dividends | | | (21,293 | ) | | | (21,293 | ) |
| | | | | | | | |
| | |
Net loss available to common stockholders | | $ | (186,399 | ) | | $ | (92,547 | ) |
| | | | | | | | |
| | |
Basic and diluted net loss per common share attributable to Alere Inc. and Subsidiaries: | | | | | | | | |
Loss from continuing operations | | $ | (2.28 | ) | | $ | (0.92 | ) |
Income (loss) from discontinued operations | | | 0.03 | | | | (0.21 | ) |
| | | | | | | | |
Net loss per common share | | $ | (2.25 | ) | | $ | (1.13 | ) |
| | | | | | | | |
| | |
Weighted average shares - basic and diluted | | | 82,938 | | | | 81,542 | |
| | | | | | | | |
Alere Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)
| | | | | | | | |
| | | December 31,
2014 | | | December 31,
2013 | |
ASSETS | | | | | | | | |
CURRENT ASSETS: | | | | | | | | |
Cash and cash equivalents | | $ | 378,461 | | | $ | 355,431 | |
Restricted cash | | | 37,571 | | | | 3,458 | |
Marketable securities | | | 259 | | | | 858 | |
Accounts receivable, net | | | 466,106 | | | | 489,392 | |
Inventories, net | | | 365,165 | | | | 362,167 | |
Prepaid expenses and other current assets | | | 221,140 | | | | 184,287 | |
Assets held for sale | | | 306,865 | | | | 355,530 | |
| | | | | | | | |
Total current assets | | | 1,775,567 | | | | 1,751,123 | |
| | |
PROPERTY, PLANT AND EQUIPMENT, NET | | | 456,767 | | | | 468,232 | |
GOODWILL AND OTHER INTANGIBLE ASSETS, NET | | | 4,256,676 | | | | 4,633,803 | |
RESTRICTED CASH - NON-CURRENT | | | — | | | | 29,370 | |
DEFERRED FINANCING COSTS AND OTHER ASSETS, NET | | | 228,030 | | | | 178,286 | |
| | | | | | | | |
Total assets | | $ | 6,717,040 | | | $ | 7,060,814 | |
| | | | | | | | |
| | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | |
CURRENT LIABILITIES: | | | | | | | | |
Short-term debt and current portions of long-term debt and capital lease obligations | | $ | 93,116 | | | $ | 55,074 | |
Liabilities related to assets held for sale | | | 126,441 | | | | 136,920 | |
Other current liabilities | | | 549,648 | | | | 520,612 | |
| | | | | | | | |
Total current liabilities | | | 769,205 | | | | 712,606 | |
| | | | | | | | |
| | |
LONG-TERM LIABILITIES: | | | | | | | | |
Long-term debt and capital lease obligations, net of current portions | | | 3,631,945 | | | | 3,786,030 | |
Deferred tax liabilities | | | 363,877 | | | | 329,249 | |
Other long-term liabilities | | | 164,925 | | | | 150,081 | |
| | | | | | | | |
Total long-term liabilities | | | 4,160,747 | | | | 4,265,360 | |
| | | | | | | | |
| | |
TOTAL EQUITY | | | 1,787,088 | | | | 2,082,848 | |
| | | | | | | | |
Total liabilities and equity | | $ | 6,717,040 | | | $ | 7,060,814 | |
| | | | | | | | |
Alere Inc. and Subsidiaries
Reconciliation to Non-GAAP Adjusted Operating Results
(in thousands, except per share amounts)
| | | | | | | | |
| | | Three Months Ended December 31, | |
| | | 2014 | | | 2013 | |
Reconciliation to Non-GAAP Adjusted Operating Income(1) | | | | | | | | |
Operating income | | $ | 35,461 | | | $ | 46,373 | |
| | |
Adjustment related to acquired software license contracts | | | 285 | | | | 470 | |
Amortization of acquisition-related intangible assets | | | 60,686 | | | | 70,347 | |
Restructuring charges | | | 21,622 | | | | 4,218 | |
Stock-based compensation expense | | | 4,701 | | | | 6,748 | |
| | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 182 | | | | 762 | |
Acquisition-related costs | | | 179 | | | | 1,315 | |
Fair value adjustments to acquisition-related contingent consideration | | | (4,765 | ) | | | (1,559 | ) |
Non-cash charge associated with acquired inventory | | | — | | | | 624 | |
Costs associated with potential business dispositions | | | 5,802 | | | | 6,134 | |
Costs associated with proxy contest | | | — | | | | 58 | |
Impairment and gain (loss) on dispositions, net | | | 7,104 | | | | (761 | ) |
| | | | | | | | |
Non-GAAP adjusted operating income | | $ | 131,257 | | | $ | 134,729 | |
| | | | | | | | |
| |
| | | Three Months Ended December 31, | |
| | | 2014 | | | 2013 | |
Reconciliation to Non-GAAP Adjusted Net Income (1) | | | | | | | | |
Net loss available to common stockholders | | $ | (28,448 | ) | | $ | (9,054 | ) |
| | |
Adjustment related to acquired software license contracts | | | 285 | | | | 470 | |
Amortization of acquisition-related intangible assets | | | 60,689 | | | | 70,289 | |
Restructuring charges | | | 21,630 | | | | 4,231 | |
Stock-based compensation expense | | | 4,701 | | | | 6,748 | |
| | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 182 | | | | 762 | |
Acquisition-related costs | | | 179 | | | | 1,315 | |
Fair value adjustments to acquisition-related contingent consideration | | | (4,765 | ) | | | (1,559 | ) |
Non-cash charge associated with acquired inventory | | | — | | | | 624 | |
Costs associated with potential business dispositions | | | 5,802 | | | | 6,134 | |
Costs associated with proxy contest | | | — | | | | 58 | |
Impairment and gain (loss) on dispositions, net | | | 7,104 | | | | (761 | ) |
Loss on sale of equity investment | | | — | | | | — | |
Interest expense recorded in connection with fees paid for certain debt modifications and the termination of our senior secured credit facility | | | 365 | | | | 364 | |
Interest accretion associated with acquisition-related compensation charges | | | 96 | | | | 99 | |
Bargain purchase gain associated with the acquisition of the Liberty business | | | — | | | | — | |
Amortization of acquisition-related intangible assets, restructuring and fair value adjustments to acquisition-related contingent consideration - discontinued operations, net of tax | | | 7,552 | | | | 9,205 | |
| | |
Income tax effects on items above | | | (16,149 | ) | | | (29,661 | ) |
| | | | | | | | |
Non-GAAP adjusted net income available to common stockholders | | $ | 59,223 | | | $ | 59,264 | |
| | | | | | | | |
| | |
Net income (loss) per diluted common share from continuing operations | | $ | (0.32 | ) | | $ | (0.06 | ) |
Net loss per diluted common share from discontinued operations | | | (0.02 | ) | | | (0.05 | ) |
| | | | | | | | |
Net loss per diluted common share | | $ | (0.34 | ) | | $ | (0.11 | ) |
| | | | | | | | |
| | |
Non-GAAP adjusted net income per diluted common share from continuing operations | | $ | 0.60 | | | $ | 0.63 | |
Non-GAAP adjusted net income (loss) per diluted common share from discontinued operations | | | 0.06 | | | | 0.05 | |
| | | | | | | | |
Non-GAAP adjusted net income per diluted common share | | $ | 0.66 | | | $ | 0.68 | |
| | | | | | | | |
| | |
Weighted average shares - diluted | | | 83,586 | | | | 81,913 | |
| | | | | | | | |
Non-GAAP adjusted weighted average shares - diluted | | | 98,409 | | | | 96,636 | |
| | | | | | | | |
| (1) | In calculating “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders”, the Company excludes (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from operating income and net income or loss allows investors and management to evaluate and compare the Company’s operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust operating income or net income or loss for the costs associated with litigation, including payments made or received through settlements. It should be noted that “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders” are not standard financial measurements under accounting principles generally accepted in the United States of America (“GAAP”) and should not be considered as an alternative to operating income and net income or loss or cash flow from operating activities, as a measure of liquidity or as an indicator of operating performance or any measure of performance derived in accordance with GAAP. In addition, all companies do not calculate non-GAAP financial measures in the same manner and, accordingly, “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders” presented in this press release may not be comparable to similar measures used by other companies. |
Alere Inc. and Subsidiaries
Reconciliation to Non-GAAP Adjusted Operating Results
(in thousands, except per share amounts)
| | | | | | | | |
| | | Year Ended December 31, | |
| | | 2014 | | | 2013 | |
Reconciliation to Non-GAAP Adjusted Operating Income(1) | | | | | | | | |
Operating income | | $ | 93,424 | | | $ | 160,404 | |
| | |
Adjustment related to acquired software license contracts | | | 1,401 | | | | 2,240 | |
Amortization of acquisition-related intangible assets | | | 237,295 | | | | 280,116 | |
Restructuring charges | | | 58,696 | | | | 14,443 | |
Stock-based compensation expense | | | 12,452 | | | | 21,210 | |
| | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 1,855 | | | | 2,794 | |
Acquisition-related costs | | | 874 | | | | 3,087 | |
Fair value adjustments to acquisition-related contingent consideration | | | 12,277 | | | | 14,736 | |
Non-cash charge associated with acquired inventory | | | — | | | | 2,504 | |
Costs associated with potential business dispositions | | | 26,565 | | | | 6,134 | |
Costs associated with proxy contest | | | — | | | | 5,525 | |
Impairment and gain (loss) on dispositions, net | | | 7,742 | | | | 5,124 | |
| | | | | | | | |
Non-GAAP adjusted operating income | | $ | 452,581 | | | $ | 518,317 | |
| | | | | | | | |
| |
| | | Year Ended December 31, | |
| | | 2014 | | | 2013 | |
Reconciliation to Non-GAAP Adjusted Net Income (1) | | | | | | | | |
Net loss available to common stockholders | | $ | (186,399 | ) | | $ | (92,547 | ) |
| | |
Adjustment related to acquired software license contracts | | | 1,401 | | | | 2,240 | |
Amortization of acquisition-related intangible assets | | | 237,341 | | | | 280,318 | |
Restructuring charges | | | 58,738 | | | | 14,502 | |
Stock-based compensation expense | | | 12,452 | | | | 21,210 | |
| | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 1,855 | | | | 2,794 | |
Acquisition-related costs | | | 874 | | | | 3,087 | |
Fair value adjustments to acquisition-related contingent consideration | | | 12,277 | | | | 14,736 | |
Non-cash charge associated with acquired inventory | | | — | | | | 2,504 | |
Costs associated with potential business dispositions | | | 26,565 | | | | 6,134 | |
Costs associated with proxy contest | | | — | | | | 5,525 | |
Impairment and gain (loss) on dispositions, net | | | 7,742 | | | | 5,124 | |
Loss on sale of equity investment | | | 457 | | | | — | |
Interest expense recorded in connection with fees paid for certain debt modifications and the termination of our senior secured credit facility | | | 1,456 | | | | 2,490 | |
Interest accretion associated with acquisition-related compensation charges | | | 391 | | | | 357 | |
Non-cash write-off of an investment | | | — | | | | 5,110 | |
Bargain purchase gain associated with the acquisition of the Liberty business | | | — | | | | (8,023 | ) |
Expense associated with extinguishment of debt | | | — | | | | 35,767 | |
Amortization of acquisition-related intangible assets, restructuring and fair value adjustments to acquisition-related contingent consideration - discontinued operations, net of tax | | | 11,776 | | | | 33,422 | |
| | |
Income tax effects on items above | | | (8,894 | ) | | | (126,822 | ) |
| | | | | | | | |
Non-GAAP adjusted net income available to common stockholders | | $ | 178,032 | | | $ | 207,928 | |
| | | | | | | | |
| | |
Net loss per diluted common share from continuing operations | | $ | (2.28 | ) | | $ | (0.92 | ) |
Net income (loss) per diluted common share from discontinued operations | | | 0.03 | | | | (0.21 | ) |
| | | | | | | | |
Net loss per diluted common share | | $ | (2.25 | ) | | $ | (1.13 | ) |
| | | | | | | | |
| | |
Non-GAAP adjusted net income per diluted common share from continuing operations | | $ | 1.90 | | | $ | 2.24 | |
Non-GAAP adjusted net income per diluted common share from discontinued operations | | | 0.17 | | | | 0.17 | |
| | | | | | | | |
Non-GAAP adjusted net income per diluted common share | | $ | 2.07 | | | $ | 2.41 | |
| | | | | | | | |
| | |
Weighted average shares - diluted | | | 82,938 | | | | 81,542 | |
| | | | | | | | |
Non-GAAP adjusted weighted average shares - diluted | | | 87,397 | | | | 95,952 | |
| | | | | | | | |
| (1) | In calculating “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders”, the Company excludes (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from operating income and net income or loss allows investors and management to evaluate and compare the Company’s operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust operating income or net income or loss for the costs associated with litigation, including payments made or received through settlements. It should be noted that “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders” are not standard financial measurements under accounting principles generally accepted in the United States of America (“GAAP”) and should not be considered as an alternative to operating income and net income or loss or cash flow from operating activities, as a measure of liquidity or as an indicator of operating performance or any measure of performance derived in accordance with GAAP. In addition, all companies do not calculate non-GAAP financial measures in the same manner and, accordingly, “Non-GAAP adjusted operating income” and “Non-GAAP adjusted net income available to common stockholders” presented in this press release may not be comparable to similar measures used by other companies. |
Alere Inc. and Subsidiaries
Selected Consolidated Revenues by Business Area(1)
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | |
Professional Diagnostics Segment | | | | | | | | | | | | | | % Change
Q4 14 v. Q4 13 | | | % Change
YTD 14 v. YTD 13 | |
| | | Q4 2014 | | | YTD 2014 | | | Q4 2013 | | | YTD 2013 | | | |
Infectious disease | | $ | 203,504 | | | $ | 710,514 | | | $ | 202,923 | | | $ | 723,213 | | | | 0 | % | | | -2 | % |
Toxicology | | | 149,241 | | | | 627,755 | | | | 151,258 | | | | 632,727 | | | | -1 | % | | | -1 | % |
Cardiology | | | 109,665 | | | | 441,582 | | | | 113,632 | | | | 463,281 | | | | -3 | % | | | -5 | % |
Diabetes | | | 46,051 | | | | 197,476 | | | | 47,350 | | | | 225,488 | | | | -3 | % | | | -12 | % |
Other(1) | | | 90,271 | | | | 342,574 | | | | 85,504 | | | | 321,495 | | | | 6 | % | | | 7 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
Professional diagnostics net product sales and services revenue(1) | | | 598,732 | | | | 2,319,901 | | | | 600,667 | | | | 2,366,204 | | | | 0 | % | | | -2 | % |
License and royalty revenue | | | 5,051 | | | | 19,738 | | | | 13,415 | | | | 24,933 | | | | -62 | % | | | -21 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
Professional diagnostics net revenue | | $ | 603,783 | | | $ | 2,339,639 | | | $ | 614,082 | | | $ | 2,391,137 | | | | -2 | % | | | -2 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Health Information Solutions Segment | | | | | | | | | | | | | | % Change
Q4 14 v. Q4 13 | | | % Change
YTD 14 v. YTD 13 | |
| | | Q4 2014 | | | YTD 2014 | | | Q4 2013 | | | YTD 2013 | | | |
Condition and case management | | $ | 4,079 | | | $ | 16,818 | | | $ | 4,119 | | | $ | 15,359 | | | | -1 | % | | | 9 | % |
Wellness | | | 675 | | | | 3,499 | | | | 1,239 | | | | 5,369 | | | | -46 | % | | | -35 | % |
Patient self-testing services | | | 29,980 | | | | 116,779 | | | | 25,483 | | | | 102,919 | | | | 18 | % | | | 13 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Health information solutions net revenue | | $ | 34,734 | | | $ | 137,096 | | | $ | 30,841 | | | $ | 123,647 | | | | 13 | % | | | 11 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
| (1) | Revenues are presented in accordance with generally accepted accounting principles and exclude an adjustment of $0.3 million and $1.4 million, and $0.5 million and $2.2 million related to acquired software license contracts which were not recognized during the three and twelve months ended December 31, 2014 and 2013, respectively, due to business combination accounting rules. |
Alere Inc. and Subsidiaries
Reconciliation of Operating Income (Loss) to Non-GAAP Adjusted Operating Income (Loss)
(in thousands)
| | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended December 31, 2014 | |
| Operating Segment | | Professional
Diagnostics | | | Health
Information
Solutions | | | Consumer
Diagnostics | | | Corporate | | | Total | |
| | | | | |
Net revenue | | $ | 603,784 | | | $ | 34,734 | | | $ | 28,339 | | | $ | — | | | $ | 666,857 | |
Adjustment related to acquired software license contracts (1) | | | 285 | | | | — | | | | — | | | | — | | | | 285 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 604,069 | | | $ | 34,734 | | | $ | 28,339 | | | $ | — | | | $ | 667,142 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Operating income (loss) | | $ | 44,096 | | | $ | (3,226 | ) | | $ | 6,947 | | | $ | (12,356 | ) | | $ | 35,461 | |
Adjustment related to acquired software license contracts (1) | | | 285 | | | | — | | | | — | | | | — | | | | 285 | |
Amortization of acquisition-related intangible assets | | | 63,006 | | | | 1,138 | | | | (2,168 | ) | | | (1,290 | ) | | | 60,686 | |
Restructuring charges | | | 14,701 | | | | 13 | | | | — | | | | 6,908 | | | | 21,622 | |
Stock-based compensation expense | | | — | | | | — | | | | — | | | | 4,701 | | | | 4,701 | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 182 | | | | — | | | | — | | | | — | | | | 182 | |
Acquisition-related costs | | | — | | | | — | | | | — | | | | 179 | | | | 179 | |
Fair value adjustments to acquisition-related contingent consideration | | | 1,435 | | | | 600 | | | | — | | | | (6,800 | ) | | | (4,765 | ) |
Costs associated with potential business dispositions | | | 133 | | | | 5,669 | | | | — | | | | — | | | | 5,802 | |
Impairment and gain (loss) on dispositions, net | | | 7,104 | | | | — | | | | — | | | | — | | | | 7,104 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted operating income (loss) | | $ | 130,942 | | | $ | 4,194 | | | $ | 4,779 | | | $ | (8,658 | ) | | $ | 131,257 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Non-GAAP adjusted operating income (loss) as % of Non-GAAP adjusted net revenue | | | 21.7 | % | | | 12.1 | % | | | 16.9 | % | | | | | | | 19.7 | % |
| | | | | | | | | | | | | | | | | | | | |
| (1) | Estimated revenue related to acquired software license contracts that was not recognized during the fourth quarter of 2014 due to business combination accounting rules. |
| | | | | | | | | | | | | | | | | | | | |
| | | For the Three Months Ended December 31, 2013 | |
| Operating Segment | | Professional
Diagnostics | | | Health
Information
Solutions | | | Consumer
Diagnostics | | | Corporate | | | Total | |
| | | | | |
Net revenue | | $ | 614,082 | | | $ | 30,841 | | | $ | 28,232 | | | $ | — | | | $ | 673,155 | |
Adjustment related to acquired software license contracts (1) | | | 470 | | | | — | | | | — | | | | — | | | | 470 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 614,552 | | | $ | 30,841 | | | $ | 28,232 | | | $ | — | | | $ | 673,625 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Operating income (loss) | | $ | 70,161 | | | $ | (3,333 | ) | | $ | 3,091 | | | $ | (23,546 | ) | | $ | 46,373 | |
Adjustment related to acquired software license contracts (1) | | | 470 | | | | — | | | | — | | | | — | | | | 470 | |
Amortization of acquisition-related intangible assets | | | 69,894 | | | | (5 | ) | | | 458 | | | | — | | | | 70,347 | |
Non-cash charge associated with acquired inventory | | | 624 | | | | — | | | | — | | | | — | | | | 624 | |
Restructuring charges | | | 3,444 | | | | 774 | | | | — | | | | — | | | | 4,218 | |
Stock-based compensation expense | | | — | | | | — | | | | — | | | | 6,748 | | | | 6,748 | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 762 | | | | — | | | | — | | | | — | | | | 762 | |
Acquisition-related costs | | | — | | | | — | | | | — | | | | 1,315 | | | | 1,315 | |
Fair value adjustments to acquisition-related contingent consideration | | | (2,859 | ) | | | 1,100 | | | | — | | | | 200 | | | | (1,559 | ) |
Costs associated with proxy contest | | | — | | | | — | | | | — | | | | 58 | | | | 58 | |
Costs associated with potential business dispositions | | | 6,134 | | | | — | | | | — | | | | — | | | | 6,134 | |
Gain on disposition | | | (761 | ) | | | — | | | | — | | | | — | | | | (761 | ) |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted operating income (loss) | | $ | 147,869 | | | $ | (1,464 | ) | | $ | 3,549 | | | $ | (15,225 | ) | | $ | 134,729 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Non-GAAP adjusted operating income (loss) as % of Non-GAAP adjusted net revenue | | | 24.1 | % | | | -4.7 | % | | | 12.6 | % | | | | | | | 20.0 | % |
| | | | | | | | | | | | | | | | | | | | |
| (1) | Estimated revenue related to acquired software license contracts that was not recognized during the fourth quarter of 2013 due to business combination accounting rules. |
Comments:
In calculating “Non-GAAP adjusted operating income (loss)” in the schedule presented above, the Company excludes from “Operating income (loss)” (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from “Operating income (loss)” allows investors and management to evaluate and compare the Company’s operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust “Operating income (loss)” for the costs associated with litigation, including payments made or received through settlements. It should be noted that “Non-GAAP adjusted operating income (loss)” is not a standard financial measurement under accounting principles generally accepted in the United States of America (“GAAP”) and should not be considered as an alternative to “Operating income (loss)” as an indicator of operating performance or any measure of performance derived in accordance with GAAP. In addition, all companies do not calculate non-GAAP financial measures in the same manner and, accordingly, “Non-GAAP adjusted operating income (loss)” presented in this schedule may not be comparable to similar measures used by other companies.
Reference should also be made to the Company’s financial results contained in our earnings press release respective to the periods presented in this schedule, which include a more detailed discussion of the adjustments to the GAAP operating results presented above.
Alere Inc. and Subsidiaries
Reconciliation of Operating Income (Loss) to Non-GAAP Adjusted Operating Income (Loss)
(in thousands)
| | | | | | | | | | | | | | | | | | | | |
| | | For the Year Ended December 31, 2014 | |
| Operating Segment | | Professional
Diagnostics | | | Health
Information
Solutions | | | Consumer
Diagnostics | | | Corporate | | | Total | |
| | | | | |
Net revenue | | $ | 2,339,639 | | | $ | 137,096 | | | $ | 109,955 | | | $ | — | | | $ | 2,586,690 | |
Adjustment related to acquired software license contracts (1) | | | 1,401 | | | | — | | | | — | | | | — | | | | 1,401 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 2,341,040 | | | $ | 137,096 | | | $ | 109,955 | | | $ | — | | | $ | 2,588,091 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Operating income (loss) | | $ | 163,434 | | | $ | (1,197 | ) | | $ | 17,566 | | | $ | (86,379 | ) | | $ | 93,424 | |
Adjustment related to acquired software license contracts (1) | | | 1,401 | | | | — | | | | — | | | | — | | | | 1,401 | |
Amortization of acquisition-related intangible assets | | | 233,693 | | | | 5,089 | | | | (1,530 | ) | | | 43 | | | | 237,295 | |
Restructuring charges | | | 44,272 | | | | 188 | | | | — | | | | 14,236 | | | | 58,696 | |
Stock-based compensation expense | | | — | | | | — | | | | — | | | | 12,452 | | | | 12,452 | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 1,855 | | | | — | | | | — | | | | — | | | | 1,855 | |
Acquisition-related costs | | | — | | | | — | | | | — | | | | 874 | | | | 874 | |
Fair value adjustments to acquisition-related contingent consideration | | | 18,238 | | | | (2,561 | ) | | | — | | | | (3,400 | ) | | | 12,277 | |
Costs associated with potential business dispositions | | | 20,578 | | | | 5,987 | | | | — | | | | — | | | | 26,565 | |
Impairment and gain (loss) on dispositions, net | | | 7,742 | | | | — | | | | — | | | | — | | | | 7,742 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted operating income (loss) | | $ | 491,213 | | | $ | 7,506 | | | $ | 16,036 | | | $ | (62,174 | ) | | $ | 452,581 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Non-GAAP adjusted operating income (loss) as % of Non-GAAP adjusted net revenue | | | 21.0 | % | | | 5.5 | % | | | 14.6 | % | | | | | | | 17.5 | % |
| | | | | | | | | | | | | | | | | | | | |
| (1) | Estimated revenue related to acquired software license contracts that was not recognized during the year ended December 31, 2014 due to business combination accounting rules. |
| | | | | | | | | | | | | | | | | | | | |
| | | For the Year Ended December 31, 2013 | |
| Operating Segment | | Professional
Diagnostics | | | Health
Information
Solutions | | | Consumer
Diagnostics | | | Corporate | | | Total | |
| | | | | |
Net revenue | | $ | 2,391,137 | | | $ | 123,647 | | | $ | 105,078 | | | $ | — | | | $ | 2,619,862 | |
Adjustment related to acquired software license contracts (1) | | | 2,240 | | | | — | | | | — | | | | — | | | | 2,240 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 2,393,377 | | | $ | 123,647 | | | $ | 105,078 | | | $ | — | | | $ | 2,622,102 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Operating income (loss) | | $ | 256,086 | | | $ | (17,349 | ) | | $ | 12,122 | | | $ | (90,455 | ) | | $ | 160,404 | |
Adjustment related to acquired software license contracts (1) | | | 2,240 | | | | — | | | | — | | | | — | | | | 2,240 | |
Amortization of acquisition-related intangible assets | | | 271,711 | | | | 6,494 | | | | 1,911 | | | | — | | | | 280,116 | |
Restructuring charges | | | 12,606 | | | | 1,837 | | | | — | | | | — | | | | 14,443 | |
Stock-based compensation expense | | | — | | | | — | | | | — | | | | 21,210 | | | | 21,210 | |
Compensation charges associated with acquisition-related contingent consideration obligations | | | 2,794 | | | | — | | | | — | | | | — | | | | 2,794 | |
Non-cash charge associated with acquired inventory | | | 2,504 | | | | — | | | | — | | | | — | | | | 2,504 | |
Acquisition-related costs | | | — | | | | — | | | | — | | | | 3,087 | | | | 3,087 | |
Fair value adjustments to acquisition-related contingent consideration | | | 10,050 | | | | 3,586 | | | | — | | | | 1,100 | | | | 14,736 | |
Costs associated with proxy contest | | | — | | | | — | | | | — | | | | 5,525 | | | | 5,525 | |
Costs associated with potential business dispositions | | | 6,134 | | | | — | | | | — | | | | — | | | | 6,134 | |
Loss on disposition | | | 5,124 | | | | — | | | | — | | | | — | | | | 5,124 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted operating income (loss) | | $ | 569,249 | | | $ | (5,432 | ) | | $ | 14,033 | | | $ | (59,533 | ) | | $ | 518,317 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | |
Non-GAAP adjusted operating income (loss) as % of Non-GAAP adjusted net revenue | | | 23.8 | % | | | -4.4 | % | | | 13.4 | % | | | | | | | 19.8 | % |
| | | | | | | | | | | | | | | | | | | | |
| (1) | Estimated revenue related to acquired software license contracts that was not recognized during the year ended December 31, 2013 due to business combination accounting rules. |
Comments:
In calculating “Non-GAAP adjusted operating income (loss)” in the schedule presented above, the Company excludes from “Operating income (loss)” (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from “Operating income (loss)” allows investors and management to evaluate and compare the Company’s operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust “Operating income (loss)” for the costs associated with litigation, including payments made or received through settlements. It should be noted that “Non-GAAP adjusted operating income (loss)” is not a standard financial measurement under accounting principles generally accepted in the United States of America (“GAAP”) and should not be considered as an alternative to “Operating income (loss)” as an indicator of operating performance or any measure of performance derived in accordance with GAAP. In addition, all companies do not calculate non-GAAP financial measures in the same manner and, accordingly, “Non-GAAP adjusted operating income (loss)” presented in this schedule may not be comparable to similar measures used by other companies.
Reference should also be made to the Company’s financial results contained in our earnings press release respective to the periods presented in this schedule, which include a more detailed discussion of the adjustments to the GAAP operating results presented above.
Alere Inc. and Subsidiaries
Reconciliations to Non-GAAP Adjusted P&L Categories
(in thousands)
| | | | | | | | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Net revenue | | $ | 666,857 | | | $ | 673,155 | |
Adjustment related to acquired software license contracts | | | 285 | | | | 470 | |
| | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 667,142 | | | $ | 673,625 | |
| | | | | | | | |
| | |
Cost of net revenue | | $ | 356,526 | | | $ | 331,217 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (17,269 | ) | | | (15,328 | ) |
Restructuring charges | | | (5,053 | ) | | | (2,253 | ) |
Stock-based compensation expense | | | (317 | ) | | | (329 | ) |
Non-cash charge associated with acquired inventory | | | — | | | | (624 | ) |
| | | | | | | | |
Non-GAAP adjusted cost of net revenue | | $ | 333,887 | | | $ | 312,683 | |
| | | | | | | | |
| | |
Non-GAAP adjusted gross profit | | $ | 333,255 | | | $ | 360,942 | |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Research and development | | $ | 29,973 | | | $ | 38,324 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (2,755 | ) | | | (1,206 | ) |
Restructuring charges | | | (1,312 | ) | | | (50 | ) |
Stock-based compensation expense | | | (299 | ) | | | (1,413 | ) |
| | | | | | | | |
Non-GAAP adjusted research and development | | $ | 25,607 | | | $ | 35,655 | |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Selling, general and administrative | | $ | 237,793 | | | $ | 258,002 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (40,662 | ) | | | (53,813 | ) |
Restructuring charges | | | (15,257 | ) | | | (1,915 | ) |
Stock-based compensation expense | | | (4,085 | ) | | | (5,006 | ) |
Compensation charges associated with acquisition-related contingent consideration obligations | | | (182 | ) | | | (762 | ) |
Acquisition-related costs | | | (179 | ) | | | (1,315 | ) |
Fair value adjustments to acquisition-related contingent consideration | | | 4,765 | | | | 1,559 | |
Costs associated with potential business dispositions | | | (5,802 | ) | | | (6,134 | ) |
Costs associated with proxy contest | | | — | | | | (58 | ) |
| | | | | | | | |
Non-GAAP adjusted selling, general and administrative | | $ | 176,391 | | | $ | 190,558 | |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
Impairment and gain (loss) on dispositions, net | | $ | 7,104 | | | $ | (761 | ) |
Impairment and gain (loss) on dispositions, net | | | (7,104 | ) | | | 761 | |
| | | | | | | | |
Non-GAAP adjusted impairment and gain (loss) on dispositions, net | | $ | — | | | $ | — | |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Interest and other income (expense), net | | $ | (55,889 | ) | | $ | (56,293 | ) |
Less adjustments: | | | | | | | | |
Restructuring charges | | | 8 | | | | 13 | |
Interest expense recorded in connection with fees paid for certain debt modifications and the termination of our senior secured credit facility | | | 365 | | | | 364 | |
| | |
Interest accretion associated with acquisition-related compensation charges | | | 96 | | | | 99 | |
| | | | | | | | |
Non-GAAP adjusted interest and other income (expense), net | | $ | (55,420 | ) | | $ | (55,817 | ) |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Provision (benefit) for income taxes | | $ | 4,836 | | | $ | (7,082 | ) |
Add: Income tax effects on Non-GAAP adjustments | | | 16,172 | | | | 29,710 | |
| | | | | | | | |
Non-GAAP adjusted provision for income taxes | | $ | 21,008 | | | $ | 22,628 | |
| | | | | | | | |
| | |
| | | Three Months Ended
December 31, 2014 | | | Three Months Ended
December 31, 2013 | |
| | |
Equity earnings of unconsolidated entities, net of tax | | $ | 3,793 | | | $ | 4,205 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | 97 | | | | 146 | |
Income tax effects on items above | | | — | | | | — | |
| | | | | | | | |
Non-GAAP adjusted equity earnings of unconsolidated entities, net of tax | | $ | 3,890 | | | $ | 4,351 | |
| | | | | | | | |
Alere Inc. and Subsidiaries
Reconciliations to Non-GAAP Adjusted P&L Categories
(in thousands)
| | | | | | | | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
| | |
Net revenue | | $ | 2,586,690 | | | $ | 2,619,862 | |
Adjustment related to acquired software license contracts | | | 1,401 | | | | 2,240 | |
| | | | | | | | |
Non-GAAP adjusted net revenue | | $ | 2,588,091 | | | $ | 2,622,102 | |
| | | | | | | | |
| | |
Cost of net revenue | | $ | 1,364,786 | | | $ | 1,297,485 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (64,511 | ) | | | (68,106 | ) |
Restructuring charges | | | (11,760 | ) | | | (6,145 | ) |
Stock-based compensation expense | | | (1,180 | ) | | | (1,126 | ) |
Non-cash charge associated with acquired inventory | | | — | | | | (2,504 | ) |
| | | | | | | | |
Non-GAAP adjusted cost of net revenue | | $ | 1,287,335 | | | $ | 1,219,604 | |
| | | | | | | | |
| | |
Non-GAAP adjusted gross profit | | $ | 1,300,756 | | | $ | 1,402,498 | |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
| | |
Research and development | | $ | 144,828 | | | $ | 159,053 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (6,476 | ) | | | (4,935 | ) |
Restructuring charges | | | (9,800 | ) | | | (1,795 | ) |
Stock-based compensation expense | | | 41 | | | | (4,054 | ) |
| | | | | | | | |
Non-GAAP adjusted research and development | | $ | 128,593 | | | $ | 148,269 | |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
| | |
Selling, general and administrative | | $ | 975,910 | | | $ | 997,796 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (166,308 | ) | | | (207,075 | ) |
Restructuring charges | | | (37,136 | ) | | | (6,503 | ) |
Stock-based compensation expense | | | (11,313 | ) | | | (16,030 | ) |
Compensation charges associated with acquisition-related contingent consideration obligations | | | (1,855 | ) | | | (2,794 | ) |
Acquisition-related costs | | | (874 | ) | | | (3,087 | ) |
Fair value adjustments to acquisition-related contingent consideration | | | (12,277 | ) | | | (14,736 | ) |
Costs associated with potential business dispositions | | | (26,565 | ) | | | (6,134 | ) |
Costs associated with proxy contest | | | — | | | | (5,525 | ) |
| | | | | | | | |
Non-GAAP adjusted selling, general and administrative | | $ | 719,582 | | | $ | 735,912 | |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
Impairment and gain (loss) on dispositions, net | | $ | 7,742 | | | $ | 5,124 | |
Impairment and gain (loss) on dispositions, net | | | (7,742 | ) | | | (5,124 | ) |
| | | | | | | | |
Non-GAAP adjusted impairment and gain (loss) on dispositions, net | | $ | — | | | $ | — | |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
| | |
Interest and other income (expense), net | | $ | (211,924 | ) | | $ | (266,605 | ) |
Less adjustments: | | | | | | | | |
Restructuring charges | | | 42 | | | | 59 | |
Interest expense recorded in connection with fees paid for certain debt modifications and the termination of our senior secured credit facility | | | 1,456 | | | | 2,490 | |
| | |
Interest accretion associated with acquisition-related compensation charges | | | 391 | | | | 357 | |
Non-cash write-off of an investment | | | — | | | | 5,110 | |
| | |
Bargain purchase gain associated with the acquisition of the Liberty business | | | — | | | | (8,023 | ) |
Expense associated with extinguishment of debt | | | — | | | | 35,767 | |
| | | | | | | | |
Non-GAAP adjusted interest and other income (expense), net | | $ | (210,035 | ) | | $ | (230,845 | ) |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
| | |
Provision (benefit) for income taxes | | $ | 66,722 | | | $ | (35,359 | ) |
Add: Income tax effects on Non-GAAP adjustments | | | 9,005 | | | | 126,914 | |
| | | | | | | | |
Non-GAAP adjusted provision for income taxes | | $ | 75,727 | | | $ | 91,555 | |
| | | | | | | | |
| | |
| | | Year Ended December 31,
2014 | | | Year Ended December 31,
2013 | |
Equity earnings of unconsolidated entities, net of tax | | $ | 17,509 | | | $ | 17,443 | |
Less adjustments: | | | | | | | | |
Amortization of acquisition-related intangible assets | | | 527 | | | | 594 | |
Loss on sale of equity investment | | | 457 | | | | — | |
Income tax effects on items above | | | — | | | | — | |
| | | | | | | | |
Non-GAAP adjusted equity earnings of unconsolidated entities, net of tax | | $ | 18,493 | | | $ | 18,037 | |
| | | | | | | | |
Alere Inc. and Subsidiaries
Reconciliations of Gross Profit/Margin to Non-GAAP Adjusted Gross Profit/Margin
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | |
| Alere Consolidated | | Three Months Ended
December 31, 2013 (1) | | | Three Months Ended
September 30, 2014 (1) | | | Three Months Ended
December 31, 2014 | |
| | | | | | |
Net revenue | | $ | 673,155 | | | | | | | $ | 647,435 | | | | | | | $ | 666,857 | | | | | |
Adjustment related to acquired software license contracts | | | 470 | | | | | | | | 324 | | | | | | | | 285 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net revenue | | | 673,625 | | | | | | | | 647,759 | | | | | | | | 667,142 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Cost of net revenue | | | 331,217 | | | | | | | | 346,513 | | | | | | | | 356,526 | | | | | |
Less adjustments: | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of acquisition-related intangible assets | | | 15,328 | | | | | | | | 15,683 | | | | | | | | 17,269 | | | | | |
Stock-based compensation expense | | | 329 | | | | | | | | 291 | | | | | | | | 317 | | | | | |
Non-cash charge associated with acquired inventory | | | 624 | | | | | | | | — | | | | | | | | — | | | | | |
Restructuring charges | | | 2,253 | | | | | | | | 5,654 | | | | | | | | 5,053 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted cost of net revenue | | | 312,683 | | | | | | | | 324,885 | | | | | | | | 333,887 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Non-GAAP adjusted gross profit/margin | | $ | 360,942 | | | | 53.6 | % | | $ | 322,874 | | | | 49.8 | % | | $ | 333,255 | | | | 50.0 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | |
| Professional Diagnostics Segment | | Three Months Ended
December 31, 2013 | | | Three Months Ended
September 30, 2014 | | | Three Months Ended
December 31, 2014 | |
| | | | | | |
Net product sales and services revenue | | $ | 600,667 | | | | | | | $ | 581,759 | | | | | | | $ | 598,732 | | | | | |
Adjustment related to acquired software license contracts | | | 470 | | | | | | | | 324 | | | | | | | | 285 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted net product sales and services revenue | | | 601,137 | | | | | | | | 582,083 | | | | | | | | 599,017 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Cost of net revenue | | | 292,183 | | | | | | | | 308,467 | | | | | | | | 314,933 | | | | | |
Less adjustments: | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of acquisition-related intangible assets | | | 16,005 | | | | | | | | 15,081 | | | | | | | | 16,747 | | | | | |
Stock-based compensation expense | | | 329 | | | | | | | | 291 | | | | | | | | 317 | | | | | |
Non-cash charge associated with acquired inventory | | | 624 | | | | | | | | — | | | | | | | | — | | | | | |
Restructuring charges | | | 2,253 | | | | | | | | 5,654 | | | | | | | | 5,053 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted cost of net revenue | | | 272,972 | | | | | | | | 287,441 | | | | | | | | 292,816 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Non-GAAP adjusted gross profit/margin | | $ | 328,165 | | | | 54.6 | % | | $ | 294,642 | | | | 50.6 | % | | $ | 306,201 | | | | 51.1 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | |
| Health Information Solutions Segment | | Three Months Ended
December 31, 2013 (1) | | | Three Months Ended
September 30, 2014 (1) | | | Three Months Ended
December 31, 2014 | |
| | | | | | |
Net product sales and services revenue | | $ | 30,841 | | | | | | | $ | 35,046 | | | | | | | $ | 34,734 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Cost of net revenue | | | 14,020 | | | | | | | | 16,596 | | | | | | | | 17,891 | | | | | |
Less adjustments: | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of acquisition-related intangible assets | | | (888 | ) | | | | | | | 577 | | | | | | | | 497 | | | | | |
Restructuring charges | | | — | | | | | | | | — | | | | | | | | — | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Non-GAAP adjusted cost of net revenue | | | 14,908 | | | | | | | | 16,019 | | | | | | | | 17,394 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
Non-GAAP adjusted gross profit/margin | | $ | 15,933 | | | | 51.7 | % | | $ | 19,027 | | | | 54.3 | % | | $ | 17,340 | | | | 49.9 | % |
| | | | | | | | | | | | | | | | | | | | | | | | |
Note:
| (1) | Restated to reflect the impact of discontinued operations |
Alere Inc. and Subsidiaries
Reconciliation of Net Loss to Non-GAAP EBITDA
(in thousands)
| | | | | | | | |
| | | Three Months Ended
December 31, 2014 | | | Year Ended
December 31, 2014 | |
| | |
Net Loss(1) | | $ | (22,915 | ) | | $ | (165,076 | ) |
Less: Income (loss) from discontinued operations, net of tax | | | (1,444 | ) | | | 2,637 | |
| | | | | | | | |
Loss from continuing operations | | | (21,471 | ) | | | (167,713 | ) |
| | |
Adjustment related to acquired software license contracts | | | 285 | | | | 1,401 | |
Income tax provision | | | 4,836 | | | | 66,722 | |
Depreciation and amortization | | | 85,163 | | | | 336,360 | |
Interest, net | | | 51,969 | | | | 206,800 | |
Non-cash stock-based compensation expense | | | 4,701 | | | | 12,452 | |
Non-cash fair value adjustments to acquisition-related contingent consideration | | | (4,765 | ) | | | 12,277 | |
Loss on sale of equity investment | | | — | | | | 457 | |
Impairment and gain (loss) on dispositions, net | | | 7,104 | | | | 7,742 | |
| | | | | | | | |
Non-GAAP EBITDA | | $ | 127,822 | | | $ | 476,498 | |
| | | | | | | | |
| (1) | Net loss for the three months and year ended December 31, 2014 includes non-interest related restructuring charges of $21.6 million and $58.7 million, respectively; $0.2 million and $0.9 million, respectively, of acquisition costs and $5.8 million and $26.6 million, respectively, of costs associated with potential business dispositions which have not been added back for purposes of computing Non-GAAP EBITDA. |
Alere Inc. and Subsidiaries
Discontinued Operations
(in thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Three
Months
Ended
March 31,
2013 | | | Three
Months
Ended
June 30,
2013 | | | Three Months
Ended
September 30,
2013 | | | Three
Months
Ended
December 31,
2013 | | | Three
Months
Ended
March 31,
2014 | | | Three
Months
Ended
June 30,
2014 | | | Three Months
Ended
September 30,
2014 | | | Three
Months
Ended
December 31,
2014 | |
| | | | | | | | |
Net product sales and services revenue | | $ | 103,776 | | | $ | 104,002 | | | $ | 102,630 | | | $ | 99,171 | | | $ | 91,382 | | | $ | 90,786 | | | $ | 89,501 | | | $ | 87,827 | |
License and royalty revenue | | | — | | | | — | | | | — | | | | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net revenue | | | 103,776 | | | | 104,002 | | | | 102,630 | | | | 99,171 | | | $ | 91,382 | | | $ | 90,786 | | | $ | 89,501 | | | $ | 87,827 | |
Cost of net revenue | | | 60,488 | | | | 57,339 | | | | 55,630 | | | | 56,760 | | | $ | 51,420 | | | $ | 50,240 | | | $ | 54,314 | | | $ | 47,140 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Gross profit (loss) | | | 43,288 | | | | 46,663 | | | | 47,000 | | | | 42,411 | | | $ | 39,962 | | | $ | 40,546 | | | $ | 35,187 | | | $ | 40,687 | |
| | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Research and development | | | 968 | | | | 736 | | | | 20 | | | | 26 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
Sales and marketing | | | 19,427 | | | | 18,488 | | | | 17,840 | | | | 17,944 | | | $ | 14,020 | | | $ | 14,862 | | | $ | 14,269 | | | $ | 13,657 | |
General and administrative | | | 31,522 | | | | 34,525 | | | | 32,264 | | | | 31,254 | | | $ | 30,121 | | | $ | 28,198 | | | $ | 16,925 | | | $ | 24,139 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating loss | | | (8,629 | ) | | | (7,086 | ) | | | (3,124 | ) | | | (6,813 | ) | | $ | (4,179 | ) | | $ | (2,514 | ) | | $ | 3,993 | | | $ | 2,891 | |
Interest and other income (expense), net | | | (254 | ) | | | (397 | ) | | | (584 | ) | | | (943 | ) | | $ | (695 | ) | | $ | (629 | ) | | $ | (266 | ) | | $ | (715 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Loss before benefit for income taxes | | | (8,883 | ) | | | (7,483 | ) | | | (3,708 | ) | | | (7,756 | ) | | $ | (4,874 | ) | | $ | (3,143 | ) | | $ | 3,727 | | | $ | 2,176 | |
Provision (benefit) for income taxes | | | (3,521 | ) | | | (2,924 | ) | | | (1,429 | ) | | $ | (3,077 | ) | | $ | (1,948 | ) | | $ | (1,047 | ) | | $ | (5,376 | ) | | $ | 3,620 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Income (loss) from discontinued operations, net of taxes | | $ | (5,362 | ) | | $ | (4,559 | ) | | $ | (2,279 | ) | | $ | (4,679 | ) | | $ | (2,926 | ) | | $ | (2,096 | ) | | $ | 9,103 | | | $ | (1,444 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
Certain items included above: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Amortization of intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of net revenue | | $ | 313 | | | $ | 837 | | | $ | 580 | | | $ | 2,328 | | | $ | 760 | | | $ | 761 | | | $ | 18,719 | | | $ | 289 | |
Sales and marketing | | | 7,918 | | | | 7,968 | | | | 7,943 | | | | 7,937 | | | | 6,125 | | | | 6,125 | | | | 6,125 | | | | 6,088 | |
General and administrative | | | 625 | | | | 631 | | | | 688 | | | | 628 | | | | 628 | | | | 628 | | | | 654 | | | | 625 | |
| | | | | | | | |
Change in fair value of contingent consideration: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
General and administrative | | | 1,700 | | | | 100 | | | | 900 | | | | 600 | | | | (1,350 | ) | | | 100 | | | | (25,071 | ) | | | — | |
| | | | | | | | |
Restructuring | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cost of net revenue | | | 411 | | | | 531 | | | | 74 | | | | 704 | | | | 42 | | | | 72 | | | | — | | | | 11 | |
Sales and marketing | | | 574 | | | | 12 | | | | | | | | 635 | | | | 7 | | | | | | | | | | | | 4 | |
General and administrative | | | 911 | | | | 5,409 | | | | 1,483 | | | | 2,179 | | | | 2,768 | | | | 378 | | | | 430 | | | | (9 | ) |
Interest and other income (expense), net | | | 39 | | | | 47 | | | | 97 | | | | 70 | | | | 113 | | | | 97 | | | | 132 | | | | 93 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 12,491 | | | | 15,535 | | | | 11,765 | | | | 15,081 | | | | 9,093 | | | | 8,161 | | | | 989 | | | | 7,101 | |
Provision for income taxes | | | (4,892 | ) | | | (6,079 | ) | | | (4,604 | ) | | | (5,876 | ) | | | (3,559 | ) | | | (3,190 | ) | | | (7,270 | ) | | | (2,783 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 7,599 | | | $ | 9,456 | | | $ | 7,161 | | | $ | 9,205 | | | $ | 5,534 | | | $ | 4,971 | | | $ | (6,281 | ) | | $ | 4,318 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
